{"id":1279,"date":"2022-07-27T15:58:29","date_gmt":"2022-07-27T06:58:29","guid":{"rendered":"https:\/\/fgb.tamagawa-seiki.com\/english\/?post_type=technology&#038;p=1279"},"modified":"2022-08-24T15:22:01","modified_gmt":"2022-08-24T06:22:01","slug":"koguchi-et-al-2021","status":"publish","type":"technology","link":"https:\/\/fgb.tamagawa-seiki.com\/english\/technology\/koguchi-et-al-2021","title":{"rendered":"Koguchi et al.(2021) [nSMOL]"},"content":{"rendered":"<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34620702\/\" target=\"_blank\" rel=\"noopener noreferrer\">Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab<\/a><br \/>\nJ Immunother Cancer 2021;9:e002663<\/p>\n","protected":false},"featured_media":0,"parent":0,"template":"","acf":[],"_links":{"self":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/technology\/1279"}],"collection":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/technology"}],"about":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/types\/technology"}],"wp:attachment":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/media?parent=1279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}